The Inflation Reduction Act of 2022, a comprehensive package of economic reforms, has been signed into law by President Biden. One of the key provisions of this legislation is aimed at reducing drug costs for seniors who have Medicare. Here’s what seniors can expect in 2023.
The Inflation Reduction Act of 2022 includes several measures designed to lower the cost of prescription drugs for seniors, including the authorization of Medicare to negotiate drug prices directly with pharmaceutical companies. This is a major victory for seniors who have struggled to afford the rising cost of prescription drugs.
Under the new law, Medicare will be able to negotiate prices with drug manufacturers, potentially lowering the cost of prescription drugs by as much as 55%. This is expected to save seniors billions of dollars in out-of-pocket expenses each year.
In addition to negotiating drug prices, the Inflation Reduction Act of 2022 includes several other measures to lower healthcare costs for seniors. One of the most significant provisions is the creation of a cap on out-of-pocket expenses for Medicare beneficiaries. Starting in 2023, seniors will be protected from high medical bills by a cap on out-of-pocket expenses, which is expected to save seniors thousands of dollars each year.
The Inflation Reduction Act of 2022 is a major win for seniors who have been struggling to afford healthcare and prescription drugs. The new law will help to ensure that seniors have access to affordable healthcare and prescription drugs, while also providing much-needed relief for those who have been burdened by high out-of-pocket expenses.
Seniors can expect to see these changes take effect in 2023. The Medicare program will be able to negotiate drug prices directly with pharmaceutical companies, and seniors will be protected from high medical bills by a cap on out-of-pocket expenses. This is a significant step forward in the fight to make healthcare more affordable for all Americans.